Top Banner
1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician and hospital performance. Analysis of patient data clustered in physicians and in clinics using hierarchical (multi-level) models. Reporting benchmarking results. Background reading: Austin PC, Goel V, van Walraven C. An introduction to multilevel regression models. Can J Public Health 2001;92:150-154. Austin PC, Tu JV, Alter DA: Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: Should we be analyzing cardiovascular outcomes data differently? Am Heart J 2003;145:27-35. Carey K: A multilevel modeling approach to analysis of patient costs under managed care. Health Econ 2000;9:435-446 .
34

1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

Dec 21, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

1

EPI235: Epi Methods in HSR

May 3, 2007 L10

Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss)

Methodologic issues in benchmarking physician and hospital performance. Analysis of patient data clustered in physicians and in clinics using hierarchical (multi-level) models. Reporting benchmarking results.

Background reading: Austin PC, Goel V, van Walraven C. An introduction to multilevel regression models. Can J Public Health 2001;92:150-154.Austin PC, Tu JV, Alter DA: Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: Should we be analyzing cardiovascular outcomes data differently? Am Heart J 2003;145:27-35.Carey K: A multilevel modeling approach to analysis of patient costs under managed care. Health Econ 2000;9:435-446 .

Page 2: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

2

Page 3: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

3

Page 4: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

4

Pennsylvania Consumer Report

www.phc4.org

Page 5: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

5

Page 6: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

6

Page 7: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

7

Page 8: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

8

Page 9: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

9

Page 10: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

10

Page 11: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

11

Quality improvement by quality measurement in NY

0

1

2

3

4

5

6

7

8

9

1989 1990 1991 1992

Year

Ris

k-ad

just

ed m

ort

alit

y .

<50 OPs

50-100 OPs

100-150 OPs

>150 OPs

Hannan ED et al. JAMA 1995

Page 12: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

12

Risk factor reporting in the NY Bypass Reporting System (%)

Risk factor 1989 1990 1991

Renal insufficiency 0.4 0.5 2.8

CHF 1.7 2.9 7.1

COPD 6.9 12.4 17.4

Unstable Angina 14.9 21.1 21.8

Low EF (<40%) 18.9 23.1 22.2

Page 13: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

13

Multilevel Modeling in Health Services Epidemiology or Hierarchical Modeling or Random Effects Modeling (mixed effects…) or Variance Components Analysis Major issue in health services research: Data clustered at multiple levels: Patients clustered by physician (provider) Physicians clustered by facility (group practice, hospital) Hospitals clustered by region Classical Epi examples: Patients clustered in studies (meta-analysis) Nutrients, food items, and meals

Page 14: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

14

Covariates: patient level (severity, comorbidity), provider level (training, experience), facility level (teaching hospital, practice guidelines), regional level (salary structure)

Cluster sizes may vary substantially Example: Patient costs increase with age Outcome: annual costs per patient Exposure: patient age Covariates: Patient level (1): gender Physician level (2): gender, practice volume -> Two level model What do we want to estimate?

1. Patient-level (covariate) effects adjusted for clustering 2. Cluster specific measures of utilization or outcomes adjusted for patient-

level risk factors (case-mix adjustment) HSR: #2 = benchmarking

Page 15: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

15

Aggregated analysis versus individual level analysis Aggregated analysis results in loss of power Individual level analysis ignores the structure of nesting within organizations: -> Ordinary least squares regression (OLS):

individual outcome and covariate data are mixed with higher level covariates.

Such 'intra-class correlation' violates the OLS assumption of random errors, i.e. independent observations with common variance In nested data the error term is composed of an individual-level and an group-level variance component. Disregarding the correlation of observations leads to underestimates of OLS standard errors and thus overestimates of the significance -> false 'positive' results. Multilevel modeling is most efficient and provides unbiased estimates of standard errors.

No Clusters

Clusters but No Clustering

Clusters with much Clustering

Extreme Clustering: Pure Lumps

Page 16: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

16

Page 17: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

17

CABG Mortality among 55 hospitals

MLwiN®

L e v e l o n e m o d e l :

iii exy 10 i = i n d i v i d u a l s ; j = p r o v i d e r L e v e l t w o : V a r i a t i o n i n i n t e r c e p t i s p r e d i c t e d b y

jj u 000

S u b s t i t u t e i n l e v e l o n e m o d e l :

ijjijjij euxy 010

V a r i a n c e c o m p o n e n t s ! F i x e d p a r a m e t e r

R a n d o m p a r a m e t e r

T h e m o d e l i s m a d e t w o - l e v e l b y a l l o w i n g t h e l i n e s f o r a l l h o s p i t a l s t o v a r y a r o u n d t h e m e a n i n t e r c e p t (

0 ) b y a n a m o u n t u 0 j , w h i c h i s n o r m a l l y d i s t r i b u t e d a r o u n d t h e m e a n .

T h e s e d e p a r t u r e s f r o m t h e a v e r a g e a r e k n o w n a s t h e l e v e l 2 r e s i d u a l s . T h e y a r e i n t e r p r e t e d a s t h e h o s p i t a l e f f e c t .

T h e t r u e l e v e l 2 r e s i d u a l s a r e u n k n o w n , b u t w e c a n e s t i m a t e t h e m w i t h t h e i r 9 5 % c o n f i d e n c e l i m i t s . T h e s e e s t i m a t e s c a n b e p l o t t e d f o r a g r a p h i c a l c o m p a r i s o n o f h o s p i t a l s .

Page 18: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

18

Page 19: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

19

Page 20: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

20

Mixed effect models: Patient level covariates = random effects, provider level covariates = fixed effects SAS for continuous (linear) outcomes: proc mixed data=temp; class doc_id; model cost= pat_age pat_sex doc_sex doc_volume /solution; random intercept /subject* = doc_id; * complete independence is assumed between subjects random intercept age /subject* = doc_id; Non-linear mixed effects models: e.g. binary outcomes, count outcomes SAS V8: proc nlinmixed Expansion to more than two levels. MLwin can handle up to 15 levels.

Page 21: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

21

SAS data format:

Patient characteristics Hospital char. Patient Hospital DCG Age gender Teaching MC

1 1 … … M 1 0.56 2 1 M 1 0.56 3 1 F 1 0.56 4 1 M 1 0.56 5 1 F 1 0.56 6 1 M 1 0.56 7 1 M 1 0.56 8 1 M 1 0.56 9 1 M 1 0.56 10 1 M 1 0.56 11 1 M 1 0.56 1 2 M 0 0.78 2 2 F 0 0.78 3 2 M 0 0.78 1 3 M 1 0.60 2 3 M 1 0.60 3 3 M 1 0.60 4 3 M … 0.60 5 3 M 0.60 6 3 F … 7 3 … 8 3 9 3 10 3 11 3 12 3 13 3 14 3

Page 22: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

22

Page 23: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

23

Page 24: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

24

Page 25: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

25

Page 26: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

26

What is the best comparator for benchmarking?1) Average of all institutions 2) Stratified by institution characteristics

Austin et al. Am Heart J 2004

Page 27: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

27

Class Exercise Background: Some previous literature has shown that hospitals that initiate education programs for patients in management of chronic stable angina have shown improved outcomes. However, hospitals that have initiated such programs tend to differ from facilities that do not implement such programs. Objective: To evaluate a group outpatient educational intervention to improve outcomes in stable angina. Specific Aims: (1) To determine whether a group outpatient education program on the management of chronic stable angina improves patient health as measured by the Seattle Angina Questionnaire (SAQ). (2) To determine what patient characteristics and facility characteristics are associated with the success of such an intervention. Resources: 30 hospitals have agreed to participate. The intervention/ non-intervention selection can only be done on a facility level, because if some patients are receiving special group education, all physicians will want their patients to participate. Therefore, we cannot randomize on a patient level! The facilities will not be self-selecting into the intervention/ non-intervention arms. Rather, the researcher (you) must decide how to allocate the educational intervention. Primary data collection on patient health status (SAQ) will be used to measure outcomes to assess the effect of the intervention. Complete during and post-intervention data, both administrative and primary data are available for all facilities. Individual participation in the group education program (i.e. percentage of sessions attended) will be recorded for those individuals in the intervention facilities. Patient characteristics will also be available for some variables, including age, gender, race, and presence of supplemental insurance. Patients’ incomes will not be known, but their zipcode will be. Facility characteristics will be available for a large number of variables including size, teaching hospital status, financial ownership status, average demographics of patients, presence of cardiology programs, staff specialties, competitive environment, expenditures per patient and average distance of patients’ zip codes to the hospital.

Page 28: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

28

Dealing with clustering

Generalized estimating equations (GEE) SAS: proc genmod

Random effects modeling (multi-level modeling)

Page 29: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

29

Effect of physician specialty on patient outcomes

Attending cardiology specialty

Austin et al. Am Heart J 2003

Page 30: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

30

Teaching hospital

Page 31: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

31

GEE vs. random effects model

Twisk, Eur J Epi, 2004

Expl.: Risk factors of increased cholesterol levels

Page 32: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

32

-6 -4 -2 0 2 4 6

-6-4

-20

24

6

Variance of Z= 1

x

Expecte

d V

alu

e Y

-6 -4 -2 0 2 4 6

-6-4

-20

24

6

Variance of Z= 2

x

Expecte

d V

alu

e Y

-6 -4 -2 0 2 4 6

-6-4

-20

24

6

Variance of Z= 3

x

Expecte

d V

alu

e Y

-6 -4 -2 0 2 4 6

-6-4

-20

24

6

Variance of Z= 4

x

Expecte

d V

alu

e Y

GEE

Rand. intercept

Page 33: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

33

-6 -4 -2 0 2 4 6

0.0

0.2

0.4

0.6

0.8

1.0

Variance of Z= 1

x

Expecte

d V

alu

e Y

-6 -4 -2 0 2 4 6

0.2

0.4

0.6

0.8

Variance of Z= 2

x

Expecte

d V

alu

e Y

-6 -4 -2 0 2 4 6

0.2

0.4

0.6

0.8

Variance of Z= 3

x

Expecte

d V

alu

e Y

-6 -4 -2 0 2 4 6

0.2

0.4

0.6

0.8

Variance of Z= 4

x

Expecte

d V

alu

e Y

GEE

Rand. intercept

Page 34: 1 EPI235: Epi Methods in HSR May 3, 2007 L10 Outcomes and Effectiveness Research 4: HMO/Network (Dr. Schneeweiss) Methodologic issues in benchmarking physician.

34

Final Note: Parameter Interpretation

Marginal parameters are often thought to be more appropriate for policy questions, “What is the difference in the rate of illness in the treated population versus the untreated?”

Conditional parameter estimates closer to individual effects, “What is the effect of treatment in an individual person?”

Conditional parameter are more clinically relevant?